Skip to main content
OpenTrials

Clinical trial condition

Cystic Fibrosis

Explore clinical trials studying Cystic Fibrosis. Study availability and eligibility vary by location and protocol.

1,061 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Cystic Fibrosis trial results

Completed

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

NCT03125395

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Ann & Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Completed

Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients

NCT02421120

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States
  • University of North Carolina Medical Center Chapel Hill, North Carolina, United States
  • St. Christopher's Hospital for Children Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

NCT01111383

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • CHR Clemenceau Caen, France
  • Hopital Arnaud de Villeneuve, Clinique des maladies respiratoires Montpellier, France
  • Hopital Necker Paris, France
  • Specjalistyczny ZOZ nad Matka i Dzieckiem, Poradnia Leczenia Mukowiscydozy Gdansk, Poland
View all 20 locations
View Trial Details
Completed

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

NCT01116089

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University Hospital Brno Bohunice Brno, Czechia
  • SMSI Institude of Cardiology Chisinau, Moldova
  • University hospital with Health Center Banská Bystrica, Slovakia
  • Fakultná nemocnica s poliklinikou Bratislava (FNsP) Brastislava, Slovakia
View Trial Details

Related conditions